Scot Middleton

1.2k total citations
15 papers, 770 citations indexed

About

Scot Middleton is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Scot Middleton has authored 15 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Scot Middleton's work include Bone Metabolism and Diseases (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Bone health and treatments (4 papers). Scot Middleton is often cited by papers focused on Bone Metabolism and Diseases (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Bone health and treatments (4 papers). Scot Middleton collaborates with scholars based in United States, Austria and Germany. Scot Middleton's co-authors include Marina Stolina, Debra Zack, Brad Bolon, Ulrich Feige, Andrew M. Havill, Paul J. Kostenuik, Georg Schett, Heather Brown, Denise Dwyer and Li Zhu and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Bone and Mineral Research and Biochemical Pharmacology.

In The Last Decade

Scot Middleton

15 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scot Middleton United States 13 387 221 176 160 133 15 770
Katharina Tschoep Germany 8 336 0.9× 53 0.2× 138 0.8× 136 0.8× 149 1.1× 11 719
Qi Shen China 17 375 1.0× 126 0.6× 188 1.1× 108 0.7× 111 0.8× 52 859
James D. Calore United States 16 232 0.6× 41 0.2× 106 0.6× 381 2.4× 165 1.2× 28 936
Mohammad Javad Fattahi Iran 17 267 0.7× 134 0.6× 316 1.8× 61 0.4× 274 2.1× 58 852
Christine Joseph United States 15 320 0.8× 104 0.5× 190 1.1× 123 0.8× 143 1.1× 25 966
Federica Savi Italy 14 284 0.7× 92 0.4× 75 0.4× 37 0.2× 115 0.9× 20 746
Ashish Saroha India 15 313 0.8× 53 0.2× 71 0.4× 97 0.6× 120 0.9× 18 561
Ann Biehl United States 5 231 0.6× 261 1.2× 283 1.6× 59 0.4× 359 2.7× 8 970
Yixin Qian China 11 887 2.3× 99 0.4× 532 3.0× 40 0.3× 92 0.7× 29 1.3k
Mette G Sørensen Denmark 14 591 1.5× 121 0.5× 324 1.8× 17 0.1× 49 0.4× 18 802

Countries citing papers authored by Scot Middleton

Since Specialization
Citations

This map shows the geographic impact of Scot Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot Middleton more than expected).

Fields of papers citing papers by Scot Middleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot Middleton. The network helps show where Scot Middleton may publish in the future.

Co-authorship network of co-authors of Scot Middleton

This figure shows the co-authorship network connecting the top 25 collaborators of Scot Middleton. A scholar is included among the top collaborators of Scot Middleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scot Middleton. Scot Middleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Frohn, Mike, Victor J. Cee, Brian A. Lanman, et al.. (2011). Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity. Bioorganic & Medicinal Chemistry Letters. 22(1). 628–633. 9 indexed citations
2.
Reed, Anthony B., Brian A. Lanman, Susana Neira, et al.. (2011). Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups. Bioorganic & Medicinal Chemistry Letters. 22(4). 1779–1783. 5 indexed citations
3.
Bolon, Brad, et al.. (2010). Rodent Preclinical Models for Developing Novel Antiarthritic Molecules: Comparative Biology and Preferred Methods for Evaluating Efficacy. BioMed Research International. 2011(1). 569068–569068. 88 indexed citations
4.
Stolina, Marina, Georg Schett, Denise Dwyer, et al.. (2009). RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies. Arthritis Research & Therapy. 11(6). R187–R187. 69 indexed citations
5.
Stolina, Marina, Brad Bolon, Denise Dwyer, et al.. (2008). The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis. Biomarkers. 13(7-8). 692–712. 23 indexed citations
6.
Stolina, Marina, Brad Bolon, Scot Middleton, et al.. (2008). The Evolving Systemic and Local Biomarker Milieu at Different Stages of Disease Progression in Rat Adjuvant-Induced Arthritis. Journal of Clinical Immunology. 29(2). 158–174. 64 indexed citations
7.
Schett, Georg, Scot Middleton, Brad Bolon, et al.. (2005). Additive bone‐protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models. Arthritis & Rheumatism. 52(5). 1604–1611. 54 indexed citations
8.
Schett, Georg, Marina Stolina, Brad Bolon, et al.. (2005). Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis & Rheumatism. 52(10). 3192–3201. 51 indexed citations
9.
Stolina, Marina, Stephen Adamu, Denise Dwyer, et al.. (2005). RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis. Journal of Bone and Mineral Research. 20(10). 1756–1765. 82 indexed citations
10.
Tamayo, Nuria, David Powers, Yanyan Tudor, et al.. (2005). Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2409–2413. 40 indexed citations
11.
Wright, Clifford D., Andrew M. Havill, Scot Middleton, et al.. (1999). Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-{4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy}-pentane (AMG-126737). Biochemical Pharmacology. 58(12). 1989–1996. 51 indexed citations
12.
Wright, Clifford D., Andrew M. Havill, Scot Middleton, et al.. (1999). Secretory Leukocyte Protease Inhibitor Prevents Allergen-Induced Pulmonary Responses in Animal Models of Asthma. Journal of Pharmacology and Experimental Therapeutics. 289(2). 1007–1014. 45 indexed citations
13.
Middleton, Scot, et al.. (1998). Tryptase mediates hyperresponsiveness in isolated Guinea Pig bronchi. Life Sciences. 63(26). 2295–2303. 24 indexed citations
14.
Guo, Jane, Eunhee S. Yi, Andrew M. Havill, et al.. (1998). Intravenous keratinocyte growth factor protects against experimental pulmonary injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 275(4). L800–L805. 68 indexed citations
15.
Deterding, Robin R., Andrew M. Havill, Takafumi Yano, et al.. (1997). Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor.. PubMed. 109(3). 254–68. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Tschoep Breakdown of academic impact, for papers by Qi Shen Breakdown of academic impact, for papers by James D. Calore Breakdown of academic impact, for papers by Mohammad Javad Fattahi Breakdown of academic impact, for papers by Christine Joseph Breakdown of academic impact, for papers by Federica Savi Breakdown of academic impact, for papers by Ashish Saroha Breakdown of academic impact, for papers by Ann Biehl Breakdown of academic impact, for papers by Yixin Qian Breakdown of academic impact, for papers by Mette G Sørensen
Rankless by CCL
2026